GFAP and depressive symptom measurement: While GFAP helps maintain astrocyte structural integrity under normal conditions, its pathological overexpression contributes to depression-associated synaptic dysfunction, mainly through impaired neurotransmitter clearance (Sălcudean et al., 2025).